Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Thomas F Gajewski, Ken Hatogai, Robin Reschke, Jovian Yu, Emily F Higgs, Blake A Flood
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/f9e279c1b9724561b39c21d3d4952698
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f9e279c1b9724561b39c21d3d4952698
record_format	dspace
spelling	oai:doaj.org-article:f9e279c1b9724561b39c21d3d49526982021-11-21T11:00:05ZImmune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma10.1136/jitc-2021-0035212051-1426https://doaj.org/article/f9e279c1b9724561b39c21d3d49526982021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e003521.fullhttps://doaj.org/toc/2051-1426Thomas F GajewskiKen HatogaiRobin ReschkeJovian YuEmily F HiggsBlake A FloodBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Thomas F Gajewski Ken Hatogai Robin Reschke Jovian Yu Emily F Higgs Blake A Flood Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
format	article
author	Thomas F Gajewski Ken Hatogai Robin Reschke Jovian Yu Emily F Higgs Blake A Flood
author_facet	Thomas F Gajewski Ken Hatogai Robin Reschke Jovian Yu Emily F Higgs Blake A Flood
author_sort	Thomas F Gajewski
title	Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
title_short	Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
title_full	Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
title_fullStr	Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
title_full_unstemmed	Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
title_sort	immune cell and tumor cell-derived cxcl10 is indicative of immunotherapy response in metastatic melanoma
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/f9e279c1b9724561b39c21d3d4952698
work_keys_str_mv	AT thomasfgajewski immunecellandtumorcellderivedcxcl10isindicativeofimmunotherapyresponseinmetastaticmelanoma AT kenhatogai immunecellandtumorcellderivedcxcl10isindicativeofimmunotherapyresponseinmetastaticmelanoma AT robinreschke immunecellandtumorcellderivedcxcl10isindicativeofimmunotherapyresponseinmetastaticmelanoma AT jovianyu immunecellandtumorcellderivedcxcl10isindicativeofimmunotherapyresponseinmetastaticmelanoma AT emilyfhiggs immunecellandtumorcellderivedcxcl10isindicativeofimmunotherapyresponseinmetastaticmelanoma AT blakeaflood immunecellandtumorcellderivedcxcl10isindicativeofimmunotherapyresponseinmetastaticmelanoma
_version_	1718419400556544000

Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

Ejemplares similares